Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen M Strittmatter

Showing results (141-150 of 194) with videos related to

Pageof 20
Sort By:
Molecular Cell|November 8, 2018
Liquid and Hydrogel Phases of PrP<sup>C</sup> Linked to Conformation Shifts and Triggered by Alzheimer's Amyloid-β OligomersMikhail A Kostylev, Marcus D Tuttle, Suho Lee, et al.
Neuron|March 17, 2009
An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizersMichael W Linhoff, Juha Laurén, Robert M Cassidy, et al.
Molecular Neurodegeneration|May 3, 2022
Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathyA Harrison Brody, Sarah Helena Nies, Fulin Guan, et al.
The Journal of Biological Chemistry|June 4, 2011
Differential but competitive binding of Nogo protein and class i major histocompatibility complex (MHCI) to the PIR-B ectodomain provides an inhibition of cellsHaruka Matsushita, Shota Endo, Eiji Kobayashi, et al.
Journal of Neurotrauma|June 26, 2014
Human NgR-Fc decoy protein via lumbar intrathecal bolus administration enhances recovery from rat spinal cord contusionXingxing Wang, Kazim Yigitkanli, Chang-Yeon Kim, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 27, 2017
Conditional Deletion of <i>Prnp</i> Rescues Behavioral and Synaptic Deficits after Disease Onset in Transgenic Alzheimer's DiseaseSantiago V Salazar, Christopher Gallardo, Adam C Kaufman, et al.
Cell Reports|October 26, 2022
Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2Caitlin M Rodriguez, Sophia C Bechek, Graham L Jones, et al.
Molecular Imaging and Biology|December 1, 2020
Quantification of SV2A Binding in Rodent Brain Using [<sup>18</sup>F]SynVesT-1 and PET ImagingPragalath Sadasivam, Xiaotian T Fang, Takuya Toyonaga, et al.
Nature Communications|August 26, 2018
Human neuroepithelial stem cell regional specificity enables spinal cord repair through a relay circuitMaria Teresa Dell'Anno, Xingxing Wang, Marco Onorati, et al.
Frontiers in Neurology|February 27, 2023
Decreased synaptic vesicle glycoprotein 2A binding in a rodent model of familial Alzheimer's disease detected by [<sup>18</sup>F]SDM-16Chao Zheng, Takuya Toyonaga, Baosheng Chen, et al.
Pageof 20

Showing results (141-150 of 194) with videos related to

Sort By:
Pageof 20
Molecular Cell|November 8, 2018
Liquid and Hydrogel Phases of PrP<sup>C</sup> Linked to Conformation Shifts and Triggered by Alzheimer's Amyloid-β OligomersMikhail A Kostylev, Marcus D Tuttle, Suho Lee, et al.
Neuron|March 17, 2009
An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizersMichael W Linhoff, Juha Laurén, Robert M Cassidy, et al.
Molecular Neurodegeneration|May 3, 2022
Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathyA Harrison Brody, Sarah Helena Nies, Fulin Guan, et al.
The Journal of Biological Chemistry|June 4, 2011
Differential but competitive binding of Nogo protein and class i major histocompatibility complex (MHCI) to the PIR-B ectodomain provides an inhibition of cellsHaruka Matsushita, Shota Endo, Eiji Kobayashi, et al.
Journal of Neurotrauma|June 26, 2014
Human NgR-Fc decoy protein via lumbar intrathecal bolus administration enhances recovery from rat spinal cord contusionXingxing Wang, Kazim Yigitkanli, Chang-Yeon Kim, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 27, 2017
Conditional Deletion of <i>Prnp</i> Rescues Behavioral and Synaptic Deficits after Disease Onset in Transgenic Alzheimer's DiseaseSantiago V Salazar, Christopher Gallardo, Adam C Kaufman, et al.
Cell Reports|October 26, 2022
Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2Caitlin M Rodriguez, Sophia C Bechek, Graham L Jones, et al.
Molecular Imaging and Biology|December 1, 2020
Quantification of SV2A Binding in Rodent Brain Using [<sup>18</sup>F]SynVesT-1 and PET ImagingPragalath Sadasivam, Xiaotian T Fang, Takuya Toyonaga, et al.
Nature Communications|August 26, 2018
Human neuroepithelial stem cell regional specificity enables spinal cord repair through a relay circuitMaria Teresa Dell'Anno, Xingxing Wang, Marco Onorati, et al.
Frontiers in Neurology|February 27, 2023
Decreased synaptic vesicle glycoprotein 2A binding in a rodent model of familial Alzheimer's disease detected by [<sup>18</sup>F]SDM-16Chao Zheng, Takuya Toyonaga, Baosheng Chen, et al.
Pageof 20